Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer ... - MarketWatch (press release)

Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer ... MarketWatch (press release) 8, 2012 /PRNewswire via COMTEX/ -- Scientists at Indiana University, Methodist Research Institute, study a botanical formula that kills aggressive prostate cancer tumors. Their findings, based on experiments in mice using a human prostate cancer tumor ... and more »

FDA questions Amgen drug for prostate cancer - USA TODAY

USA TODAY

FDA questions Amgen drug for prostate cancer USA TODAY WASHINGTON – Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects. Benefit of Bone Drug in Prostate Cancer in DoubtMedPage Today FDA doubts benefits of Amgen drug for prostate cancerGlobalPost FDA Questions Benefit of Amgen Bone Drug in Certain CasesWall Street Journal (blog) DailyFinance all 222 news articles »